Magnus Rizell Transplant Institute Institute of Clinical Sciences Biography Publications Institution JoVE Articles Magnus Rizell has not added a biography. If you are Magnus Rizell and would like to personalize this page please email our Author Liaison for assistance. Publications Attitudes Towards Organ Donor Advocacy Among Swedish Intensive Care Nurses Nursing in Critical Care. Jan, 2015 | Pubmed ID: 25611200 Isolated Hepatic Perfusion As a Treatment for Uveal Melanoma Liver Metastases (the SCANDIUM Trial): Study Protocol for a Randomized Controlled Trial Trials. 2014 | Pubmed ID: 25106493 Cyclosporine A and Tacrolimus Reduce the Amount of GLUT4 at the Cell Surface in Human Adipocytes: Increased Endocytosis As a Potential Mechanism for the Diabetogenic Effects of Immunosuppressive Agents The Journal of Clinical Endocrinology and Metabolism. Oct, 2014 | Pubmed ID: 25004245 FKBP5 Expression in Human Adipose Tissue Increases Following Dexamethasone Exposure and is Associated with Insulin Resistance Metabolism: Clinical and Experimental. Sep, 2014 | Pubmed ID: 24997500 Characterization of Brown Adipose Tissue in the Human Perirenal Depot Obesity (Silver Spring, Md.). Aug, 2014 | Pubmed ID: 24753268 The Immunosuppressive Agents Rapamycin, Cyclosporin A and Tacrolimus Increase Lipolysis, Inhibit Lipid Storage and Alter Expression of Genes Involved in Lipid Metabolism in Human Adipose Tissue Molecular and Cellular Endocrinology. Jan, 2013 | Pubmed ID: 23160140 [Selection Criteria Decisive in Hepatocellular Carcinoma] Läkartidningen. Sep 26-Oct 9, 2012 | Pubmed ID: 23097883 Radiation Exposure During Liver Surgery After Treatment with (90)Y Microspheres, Evaluated with Computer Simulations and Dosimeter Measurements Journal of Radiological Protection : Official Journal of the Society for Radiological Protection. Dec, 2012 | Pubmed ID: 23079691 MTOR Inhibition with Rapamycin Causes Impaired Insulin Signalling and Glucose Uptake in Human Subcutaneous and Omental Adipocytes Molecular and Cellular Endocrinology. May, 2012 | Pubmed ID: 22333157 [Living Donor Kidney Transplantation--a Successful Story. Very Cost-effective--and the Donors Live Long with Good Health] Läkartidningen. Nov 30-Dec 6, 2011 | Pubmed ID: 22462270 Development and Psychometric Evaluation of the Instrument: Attitudes Towards Organ Donor Advocacy Scale (ATODAS) The Open Nursing Journal. 2011 | Pubmed ID: 22046210 Attitudes to Organ Donation Among Swedish ICU Nurses Journal of Clinical Nursing. Nov, 2011 | Pubmed ID: 21564363 Post-nephrectomy Development of Renal Function in Living Kidney Donors: a Cross-sectional Retrospective Study Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. Jul, 2011 | Pubmed ID: 21459783 Liver Transplantation for Cholangiocarcinoma: Selection is Essential for Acceptable Results Scandinavian Journal of Gastroenterology. Mar, 2011 | Pubmed ID: 21073376 A Prospective Randomised, Open-labeled, Trial Comparing Sirolimus-containing Versus MTOR-inhibitor-free Immunosuppression in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma BMC Cancer. 2010 | Pubmed ID: 20459775 Isolated Hepatic Perfusion for Liver Metastases of Malignant Melanoma Melanoma Research. Apr, 2008 | Pubmed ID: 18337648 Effects of the MTOR Inhibitor Sirolimus in Patients with Hepatocellular and Cholangiocellular Cancer International Journal of Clinical Oncology. Feb, 2008 | Pubmed ID: 18307022 Incidence of End-stage Renal Disease Among Live Kidney Donors Transplantation. Dec, 2006 | Pubmed ID: 17198252 Obstacles to Organ Donation in Swedish Intensive Care Units Intensive Care Medicine. May, 2006 | Pubmed ID: 16550371 [Obstacles for Recruiting Organ Donors in Intensive Care Units Can Be Overcomed. Identified Obstacles Are Attitudes, Ethics, Resources and Competence, As Shown by an Inquiry] Läkartidningen. Nov 7-13, 2005 | Pubmed ID: 16342544 Impressive Regression of Primary Liver Cancer After Treatment with Sirolimus Acta Oncologica (Stockholm, Sweden). 2005 | Pubmed ID: 16118084 Inhibition of MTOR Suppresses Experimental Liver Tumours Anticancer Research. Mar-Apr, 2005 | Pubmed ID: 15868910 Combined Treatment with Histamine Dihydrochloride, Interleukin-2 and Interferon-alpha in Patients with Metastatic Melanoma Anticancer Research. May-Jun, 2004 | Pubmed ID: 15274364 [Treatment of Patients with Liver Metastases from Colorectal Cancer. More Patients Can Benefit from the Treatment!] Läkartidningen. Aug, 2003 | Pubmed ID: 14531128 Monotherapy with Histamine Dihydrochloride Suppresses in Vivo Growth of a Rat Sarcoma in Liver and Subcutis Anticancer Research. Jul-Aug, 2002 | Pubmed ID: 12174868 Histamine Pharmacokinetics in Tumor and Host Tissues After Bolus-dose Administration in the Rat Life Sciences. Jan, 2002 | Pubmed ID: 11853233 Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma Ilan Ben-Shabat1,4, Christoffer Hansson2,4, Malin Sternby Eilard3,4, Christian Cahlin3,4, Magnus Rizell3,4, Per Lindnér3,4, Jan Mattsson1,4, Roger Olofsson Bagge1,4 1Department of Surgery, Institute of Clinical Sciences, 2Department of Thoracic Surgery, Institute of Clinical Sciences, 3Transplant Institute, Institute of Clinical Sciences, 4Sahlgrenska University Hospital, Sahlgrenska Academy at the University of Gothenburg JoVE 52490 Medicine
Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma Ilan Ben-Shabat1,4, Christoffer Hansson2,4, Malin Sternby Eilard3,4, Christian Cahlin3,4, Magnus Rizell3,4, Per Lindnér3,4, Jan Mattsson1,4, Roger Olofsson Bagge1,4 1Department of Surgery, Institute of Clinical Sciences, 2Department of Thoracic Surgery, Institute of Clinical Sciences, 3Transplant Institute, Institute of Clinical Sciences, 4Sahlgrenska University Hospital, Sahlgrenska Academy at the University of Gothenburg JoVE 52490 Medicine
